MedTrace Logo

Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation

NCT06763081 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2025-09-08

No results posted yet for this study

Summary

The purpose of this study is to identify and validate a panel of genetic markers associated with selective serotonin reuptake inhibitors (SSRI)-induced behavioural activation in children and youth with major depressive disorder (MDD), anxiety disorders, or obsessive-compulsive disorder (OCD) that could be used clinically to reduce the incidence of this adverse event and improve health outcomes.

Conditions

Interventions

OTHER

Not applicable- observational study

It's an observational study. Participants are not assigned an intervention as part of the study.

Sponsors & Collaborators

  • Health Sciences Centre Foundation, Manitoba

    collaborator OTHER

  • Children's Hospital Research Institute of Manitoba

    collaborator OTHER

  • University of Calgary Cumming School of Medicine

    collaborator UNKNOWN

  • University of Manitoba

    lead OTHER

Eligibility

Min Age
6 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2028-12-31
Completion
2030-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06763081 on ClinicalTrials.gov